Plumbagin reduces human colon cancer cell survival by inducing cell cycle arrest and mitochondria-mediated apoptosis
Authors:
Open Access
- 8 August 2014
- journal article
- research article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 45 (5) , 1913-1920
Abstract
Despite increased use of early detection methods and more aggressive treatment strategies, the worldwide incidence of colorectal cancer is still on the rise. Consequently, it remains urgent to identify novel agents with enhanced efficacy in prevention and/or therapeutic protocols. Our studies focused on the use of Plumbagin, a natural phytochemical that showed promising results against other tumor types, to determine its effectiveness in blocking the proliferation and survival of colon cancer cells in experimental protocols mimicking the environment in primary tumors (attached culture conditions) and in circulating tumor cells (unattached conditions). Under both experimental settings, exposure of HCT116 cells to Plumbagin concentrations in the low micromolar range resulted in cell cycle arrest at the G1 phase, apoptosis via the mitochondrial cell death pathway, and increased production of reactive oxygen species. The cell cycle effects were more noticeable in attached cells, whereas the induction of cell death was more evident in unattached cells. These effects were consistent with the nature and the magnitude of the alterations induced by Plumbagin on the expression levels of a set of proteins known to play key roles in the regulation of cell cycle dynamics, apoptosis mechanisms and cell proliferation. In light of its previously reported lack of toxicity on normal colon cells and the striking anti-survival effect on colon cancer cells observed in our study, Plumbagin should be considered a promising drug for the treatment of colon cancer.Keywords
This publication has 45 references indexed in Scilit:
- Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivoInternational Journal of Cancer, 2012
- Apoptosis Inducing Effect of Plumbagin on Colonic Cancer Cells Depends on Expression of COX-2PLOS ONE, 2011
- Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticalsCancer and Metastasis Reviews, 2010
- Plumbagin inhibits proliferative and inflammatory responses of T cells independent of ROS generation but by modulating intracellular thiolsJournal of Cellular Biochemistry, 2010
- Reactive oxygen species, cellular redox systems, and apoptosisFree Radical Biology and Medicine, 2010
- The role of BH3-only protein Bim extends beyond inhibiting Bcl-2–like prosurvival proteinsJournal of Cell Biology, 2009
- Metastasis: from dissemination to organ-specific colonizationNature Reviews Cancer, 2009
- Plumbagin induces reactive oxygen species, which mediate apoptosis in human cervical cancer cellsMolecular Carcinogenesis, 2004
- Apoptosis-based drug screening and detection of selective toxicity to cancer cellsAnti-Cancer Drugs, 2003
- Niosomal Plumbagin with Reduced Toxicity and Improved Anticancer Activity in BALB/C MiceJournal of Pharmacy and Pharmacology, 1996